Quantcast

Latest Osteonecrosis of the jaw Stories

2012-05-16 11:07:11

Bone cancer-related fractures and pain can be reduced by drug treatment, but no one drug is superior, according to a review published in The Cochrane Library. Researchers undertook a systematic review of the current evidence on bisphosphonate drugs, which are used to prevent bone damage in multiple myeloma. Multiple myeloma is a type of cancer that grows in and on bones, and can cause fractures in long bones and the spine. Severe back pain is a common symptom. Bisphosphonate drugs may help...

2012-05-12 23:00:26

Ennis & Ennis P.A. Announces Free Nationwide Consultations to Patients Who Have Suffered Fosamax Femur Fractures or Osteonecrosis of the Jaw as FDA Confirms Long-Term Use of Fosamax Weakens Bones (PRWEB) May 12, 2012 According to an FDA review of biphosphonates published on May 9, 2012 in the New England Journal of Medicine, long term use of these drugs, commonly known as Boniva or Fosamax, could lead to weakened bones. In these cases, women suffered Fosamax side effects including...

FDA Report Suggests Women Reassess Bone Drug Use Due To Serious Adverse Events
2012-05-11 12:45:33

A new analysis of popular bone-building drugs by the US Food and Drug Administration (FDA) could prompt millions of women to rethink their use of such drugs, even though the agency fell short of issuing specific recommendations. The FDA said doctors need to reassess which women are likely to benefit from bisphosphonates such as Fosamax, Actonel and Reclast, given the lack of concrete evidence that taking them over long periods really helps them and the possibility that they can put some...

2012-05-10 09:50:59

ASBMR calls for more research to refine recommendations further The Food and Drug Administration (FDA) announced today that physicians should reassess patients with osteoporosis who are being treated with a class of drugs called bisphosphonates after three to five years of therapy to determine whether they should continue treatment. Bisphosphonates are a widely prescribed class of drugs that are proven to be effective in reducing common bone fractures in people with osteoporosis and at...

2012-05-10 09:47:22

Previous UCSF Research Found Overall Reduction in Spine Fractures, But Not for Other Types of Fractures Continuing a popular but controversial treatment for osteoporosis could reduce spine fracture risk for a particular group of patients, but others could see little to no change if they discontinue it. Based on available evidence, a UCSF researcher reevaluated his 2006 finding from a randomized 10-year study of alendronate, a type of bisphosphonate — a class of drugs that prevent...

2012-04-05 23:00:46

On March 19th, 2012 the US FDA announced the approval of the first Boniva generics to treat or prevent osteoporosis. Boniva and Fosamax belong to the class of drugs known as bisphosphonates. Fosamax, manufactured by Merck, is a drug approved by the FDA in 1995 to treat osteoporosis and other bone-related diseases. On February 27th, 2012, a jury trial began in the Superior Court for Atlantic County, New Jersey in In re: Fosamax Litigation (No. 282). Plaintiffs allege that using Fosamax caused...

2012-03-28 00:20:14

Measures to help reduce the risk of bone loss and fracture must be taken for individuals on longer-term oral glucocorticoid therapy Millions of people around the world are prescribed glucocorticoids for a wide variety of inflammatory conditions, including, rheumatoid arthritis, asthma and inflammatory bowel diseases. Although they are effective and widely used, one of the potentially serious side effects of these medications is glucocorticoid-induced osteoporosis. Osteoporosis is a...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.